CRISPR Therapeutics AG PE Ratio 2015-2019 | CRSP

Current and historical p/e ratio for CRISPR Therapeutics AG (CRSP) from 2015 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CRISPR Therapeutics AG PE ratio as of December 04, 2019 is 0.00.
CRISPR Therapeutics AG PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-04 72.10 0.00
2019-09-30 40.99 $-0.46 0.00
2019-06-30 47.10 $-3.93 0.00
2019-03-31 35.72 $-3.74 0.00
2018-12-31 28.57 $-3.43 0.00
2018-09-30 44.35 $-2.51 0.00
2018-06-30 58.76 $-2.06 0.00
2018-03-31 45.71 $-1.80 0.00
2017-12-31 23.48 $-1.72 0.00
2017-09-30 17.87 $-1.32 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.788B $0.003B
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.730B 15.98
CSL (CSLLY) Australia $87.783B 0.00
Gilead Sciences (GILD) United States $83.651B 10.36
Vertex Pharmaceuticals (VRTX) United States $56.776B 57.95
Biogen (BIIB) United States $52.759B 9.06
Illumina (ILMN) United States $46.991B 51.56
Regeneron Pharmaceuticals (REGN) United States $40.193B 17.60
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.986B 12.34
Incyte (INCY) United States $20.349B 47.24
Seattle Genetics (SGEN) United States $20.066B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.617B 64.56
BioMarin Pharmaceutical (BMRN) United States $14.345B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.220B 0.00
Galapagos (GLPG) Belgium $10.711B 27.60
Exact Sciences (EXAS) United States $10.514B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.719B 31.69
BeiGene (BGNE) Cayman Islands $9.696B 0.00
Bio-Techne Corp (TECH) United States $8.304B 55.58
Sarepta Therapeutics (SRPT) United States $8.109B 0.00
Amarin (AMRN) Ireland $7.644B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.051B 0.00
Guardant Health (GH) United States $6.934B 0.00
Medicines (MDCO) United States $6.690B 0.00
Moderna (MRNA) United States $6.585B 0.00
Reata Pharmaceuticals (RETA) United States $5.992B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.981B 15.20
ARGENX SE-ADR (ARGX) Netherlands $5.630B 0.00
Exelixis (EXEL) United States $5.074B 14.27
Ascendis Pharma (ASND) Denmark $4.663B 0.00
China Biologic Products (CBPO) China $4.591B 25.86
Repligen (RGEN) United States $4.586B 83.11
Bluebird Bio (BLUE) United States $4.440B 0.00
Spark Therapeutics (ONCE) United States $4.288B 0.00
Mirati Therapeutics (MRTX) United States $3.974B 0.00
MorphoSys AG (MOR) Germany $3.860B 0.00
Blueprint Medicines (BPMC) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.676B 0.00
Immunomedics (IMMU) United States $3.625B 0.00
Adaptive Biotechnologies (ADPT) United States $3.419B 0.00
Alkermes (ALKS) Ireland $3.240B 0.00
Genmab (GMAB) Denmark $3.045B 6.27
MyoKardia (MYOK) United States $3.013B 0.00
Emergent Biosolutions (EBS) United States $2.768B 27.50
Halozyme Therapeutics (HALO) United States $2.753B 0.00
NeoGenomics (NEO) United States $2.684B 142.83
Amicus Therapeutics (FOLD) United States $2.640B 0.00
Acceleron Pharma (XLRN) United States $2.633B 0.00
UniQure (QURE) Netherlands $2.390B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
Zai Lab (ZLAB) China $2.317B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.261B 0.00
RA PHARMCTL INC (RARX) United States $2.204B 0.00
Insmed (INSM) United States $2.062B 0.00
Cambrex (CBM) United States $2.023B 25.53
Ligand Pharmaceuticals (LGND) United States $1.957B 37.64
Myriad Genetics (MYGN) United States $1.874B 27.68
Dicerna Pharmaceuticals (DRNA) United States $1.812B 0.00
Akcea Therapeutics (AKCA) United States $1.685B 0.00
Zymeworks (ZYME) Canada $1.655B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.643B 0.00
Denali Therapeutics (DNLI) United States $1.627B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.543B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
REGENXBIO (RGNX) United States $1.497B 0.00
Epizyme (EPZM) United States $1.435B 0.00
Innoviva (INVA) United States $1.304B 3.84
Coherus BioSciences (CHRS) United States $1.294B 0.00
Alector (ALEC) United States $1.283B 0.00
Arvinas (ARVN) United States $1.280B 0.00
Sangamo Therapeutics (SGMO) United States $1.239B 0.00
Athenex (ATNX) United States $1.217B 0.00
WAVE Life Sciences (WVE) Singapore $1.174B 0.00
Principia Biopharma (PRNB) United States $1.165B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.072B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.059B 0.00
Cara Therapeutics (CARA) United States $1.036B 0.00
Zealand Pharma (ZEAL) Denmark $0.950B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.925B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.914B 7.68
Codexis (CDXS) United States $0.904B 0.00
Revance Therapeutics (RVNC) United States $0.903B 0.00
Clovis Oncology (CLVS) United States $0.901B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.865B 0.00
Precision BioSciences (DTIL) United States $0.859B 0.00
Vericel (VCEL) United States $0.847B 315.67
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Intellia Therapeutics (NTLA) United States $0.835B 0.00
Anika Therapeutics (ANIK) United States $0.807B 26.19
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
MiMedx (MDXG) United States $0.781B 0.00
Twist Bioscience (TWST) United States $0.756B 0.00
Heska (HSKA) United States $0.743B 189.78
ANI Pharmaceuticals (ANIP) United States $0.726B 12.38
DBV Technologies S.A (DBVT) France $0.704B 0.00
Adverum Biotechnologies (ADVM) United States $0.687B 0.00
UROGEN PHARMA (URGN) United States $0.654B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.654B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.629B 0.00
BioDelivery Sciences (BDSI) United States $0.620B 0.00
Mesoblast (MESO) Australia $0.610B 0.00
Cellectis S.A (CLLS) France $0.608B 0.00
GENFIT S.A (GNFT) France $0.583B 0.00
Retrophin (RTRX) United States $0.569B 0.00
Sorrento Therapeutics (SRNE) United States $0.563B 0.00
Kadmon Holdings (KDMN) United States $0.562B 0.00
Cytokineticsorporated (CYTK) United States $0.559B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Agenus (AGEN) United States $0.545B 0.00
Intra-Cellular Therapies (ITCI) United States $0.541B 0.00
AC Immune SA (ACIU) Switzerland $0.530B 12.27
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.513B 0.00
Prothena (PRTA) Ireland $0.491B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Dynavax Technologies (DVAX) United States $0.455B 0.00
Puma Biotechnology (PBYI) United States $0.418B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Bellus Health (BLU) Canada $0.383B 0.00
Arcus Biosciences (RCUS) United States $0.370B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.369B 0.00
PDL BioPharma (PDLI) United States $0.359B 8.97
OSMOTICA PHARM (OSMT) United States $0.347B 0.00
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.336B 2.32
Xenon Pharmaceuticals (XENE) Canada $0.318B 0.00
Pfenex (PFNX) United States $0.316B 0.00
Gritstone Oncology (GRTS) United States $0.309B 0.00
Avid Bioservices (CDMO) United States $0.301B 0.00
Kindred Biosciences (KIN) United States $0.301B 0.00
Compugen (CGEN) Israel $0.301B 0.00
Kamada (KMDA) Israel $0.298B 8.72
Geron (GERN) United States $0.286B 0.00
Cue Biopharma (CUE) United States $0.283B 0.00
ADMA Biologics Inc (ADMA) United States $0.278B 0.00
CytomX Therapeutics (CTMX) United States $0.273B 0.00
Seres Therapeutics (MCRB) United States $0.264B 0.00
Albireo Pharma (ALBO) United States $0.263B 0.00
Cel-Sci (CVM) United States $0.263B 0.00
Sutro Biopharma (STRO) United States $0.260B 0.00
MannKind (MNKD) United States $0.258B 0.00
Scholar Rock Holding (SRRK) United States $0.253B 0.00
Inovio Pharmaceuticals (INO) United States $0.251B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.243B 0.00
Protagonist Therapeutics (PTGX) United States $0.241B 0.00
Spero Therapeutics (SPRO) United States $0.233B 0.00
Biofrontera AG (BFRA) Germany $0.232B 0.00
Exicure (XCUR) United States $0.232B 0.00
Theratechnologies (THTX) Canada $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
ChromaDex (CDXC) United States $0.212B 0.00
XOMA (XOMA) United States $0.211B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.204B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.203B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.198B 0.00
Senesco Technologies (ELOX) United States $0.197B 0.00
Affimed (AFMD) Germany $0.191B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Palatin Technologies (PTN) United States $0.184B 5.01
Abeona Therapeutics (ABEO) United States $0.174B 0.00
Dyadic (DYAI) United States $0.170B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.167B 0.00
IVERIC Bio (ISEE) United States $0.162B 0.00
Cerecor (CERC) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Alcobra (ARCT) United States $0.156B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.149B 0.00
NantKwest (NK) United States $0.149B 0.00
Five Prime Therapeutics (FPRX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.141B 0.00
Novavax (NVAX) United States $0.139B 0.00
TELA Bio (TELA) United States $0.135B 0.00
Prometic Life Sciences (LMNL) Canada $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.126B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.125B 0.00
BioTime (LCTX) United States $0.124B 6.35
Arsanis (XFOR) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Proteostasis Therapeutics (PTI) United States $0.123B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.122B 0.00
ARAVIVE, INC (ARAV) United States $0.121B 0.00
Celyad SA (CYAD) Belgium $0.114B 0.00
Emmaus Life Sciences (EMMA) United States $0.107B 0.00
OvaScience (MLND) United States $0.104B 0.00
Verastem (VSTM) United States $0.103B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.68
Aduro Biotech (ADRO) United States $0.096B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Arbutus Biopharma (ABUS) Canada $0.093B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.083B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
Liquidia Technologies (LQDA) United States $0.078B 0.00
Acorda Therapeutics (ACOR) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.067B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Catalyst Biosciences (CBIO) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Trevena (TRVN) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Pluristem Therapeutics (PSTI) Israel $0.057B 0.00
Curis (CRIS) United States $0.054B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Orgenesis (ORGS) United States $0.050B 3.25
Merrimack Pharmaceuticals (MACK) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
Protalix BioTherapeutics (PLX) Israel $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.045B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.032B 0.00
VIVUS (VVUS) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
Unum Therapeutics (UMRX) United States $0.022B 0.00
Soligenix (SNGX) United States $0.020B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Advaxis (ADXS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.003B 0.00